Avastin’s Future in FDA’s Hands

Avastin, the wonder drug which has been the last resort for many women suffering metastatic breast cancer, risked being disapproved by the FDA last December. Obviously, this is not good news for many advance-stage breast cancer patients.

Nearly 17,500 women rely on Avastin, an advanced stage breast cancer drug that helps reduce blood flow to tumors , thus slowing their growth, and even completely wiping out the tumors in some cases. Therefore, the drug helps women survive much longer.

Blindness in Premature Babies can be Prevented With Drug Avastin
Premature babies who are born before their eyes develop fully carry a risk of blindness, like the case of famous singer, Stevie Wonder.

Avastin is expensive and patients need to spend more than $90,000 a year on treatment.

Source-Medindia

FDA Urged to Withdraw Approval of Avastin for Breast Cancer Treatment
A panel of experts on Tuesday recommended that the US Food and Drug Administration (FDA) withdraw approval of Roche's best-selling cancer drug Avastin for the treatment of breast cancer.

Approval for Roche�s Avastin may be Withdrawn
Swiss healthcare giant Roche could receive a big blow with US and European health regulators expected to cancel the approval of its breast cancer drug Avastin.

Cancer Drug, Chemotherapy Combo Raises Death Risk
The cancer drug Avastin, also known as bevacizumab, is linked to a higher risk of death when combined with chemotherapy, said a study in the Journal of the American Medical Association.